NCT06293781

Application of the Web-based Acceptance and Commitment Therapy for Depression

The Efficacy and Treatment Mechanisms of the Web-based Acceptance and Commitment Therapy for Patients With Major Depressive Disorder
Gachon University·ClinicalTrials.gov·device·Device trialRecruiting
View on ClinicalTrials.gov
Study focus
Disease/Condition
Major Depressive Disorder
Drug/Device/Intervention
Web-based ACT
Study type
Interventional
Intervention type
device
Sponsor & location
Primary sponsor
Gachon University
Location
Incheon, South Korea
Timeline & enrollment
Phase
N/A
Start date
Dec 19, 2022
End date
Feb 28, 2025
Enrollment
50 participants
Primary outcome

Acceptance and Action Questionnaire-II

Summary

PROSPECTIVE INTERVENTION STUDY; EFFICACY OF WEB-BASED ACCEPTANCE AND COMMITMENT THERAPY

ICD-10 classifications
Recurrent depressive disorderRecurrent depressive disorder, unspecifiedDepressive conduct disorderOther recurrent depressive disordersRecurrent depressive disorder, current episode moderate
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06293781
Type
Device Trial
About this record

Access comprehensive clinical trial information for NCT06293781 through Pure Global AI's free database. This phase not specified trial is sponsored by Gachon University and is currently Recruiting. The study focuses on Major Depressive Disorder. Target enrollment is 50 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.